Trial
NCT01549769
Pharmacokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes
Phase ITERMINATEDSAFETYConfidence: HIGH
Sponsor
Biogen
Collaborators
—
Condition
Renal Insufficiency, Chronic
Intervention
Bardoxolone Methyl
Why stopped
IDMC recommendation for safety concerns
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-29